ArticleArchives of virology2023

An oncolytic herpes simplex virus type 1 strain expressing a single-chain variable region antibody fragment against PD-1 and a PI3K inhibitor synergize to elicit antitumor immunity in ovarian cancer.

Shanying Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.